Two-Point Rise in PSA Before Diagnosis Identifies Men at High-Risk for Prostate Cancer Death

Armen Hareyan's picture
Advertisement

Prostate Cancer

Physicians and researchers continue to study prostate-specific antigen, or PSA, to establish guidelines on how to most effectively use the biomarker to identify prostate cancer and its aggressiveness.

Advertisement